| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |